October 28-29, 2021 | 10:00AM EDT | 2:00PM UTC | 4:00PM CEST*
*Program is in development and subject to change
The live portion of this conference has concluded and all presentations are now available for purchase on demand. Registrants to the live event may access this content anytime for up to 3 months following the event.
Keystone Symposia welcomes the global scientific community and aims to connect researchers within and across disciplines to accelerate the advancement of biomedical and life sciences. This form may be used for scientists from low- and middle-income countries of all career stages to determine eligibility and request free access to scientific content presented during recent eSymposia events. If eligible, you will be sent an access code for the On Demand content of the eSymposia event(s) of interest. Application must be completed by February 1, 2022.
Worldwide, deaths from adverse pregnancy outcomes of preterm birth (PTB) and stillbirth (SB) represent the longest, deadliest pandemic in human history. Neonatal infection (e.g. sepsis) is the main cause of death for children under 5 years; with premature babies being especially susceptible to infection. While the final common pathway for SB, PTB and neonatal sepsis is associated with aberrant inflammation in the maternal-fetal dyad, lack of insight into the underlying mechanisms has hampered identification of effective upstream preventative or downstream therapeutic interventions. A focus on immune regulation during pregnancy and in early life is thus urgently warranted. This interdisciplinary Keystone Conference on maternal-fetal-newborn immunity brings together the world’s experts across maternal, fetal and neonatal/infant immunity for the first time with the following goals:
‣ For Short Talk Consideration: Passed
‣ For ePoster Presentation: Passed
Final ePoster / SciTalk Submission: Passed
Financial Aid Application: Passed
*Abstract submission is required in order to submit an ePoster and/or Scitalk
Kjersti M. Aagaard
Baylor College of Medicine and Texas Children’s Hospital, USA
MIT and Harvard University, USA
University Medical Center Hamburg, Germany
Carolyn B. Coyne
Duke University, USA
Stanford University School of Medicine, USA
Kevin C. Kain
University of Toronto, Canada
Sabra L. Klein
Johns Hopkins University, USA
Tobias R. Kollmann
Telethon Kids Institute, Australia
London School of Hygiene & Tropical Medicine, UK
University of California, San Francisco, USA
Université libre de Bruxelles, Belgium
Mihai G. Netea
Radboud University, Netherlands
Ajoke Sobanjo-ter Meulen
Bill and Melinda Gates Foundation, USA
Cincinnati Children's Hospital, USA
University of Western Australia, Australia
Hannover Medical School, Germany
Sing Sing Way
Cincinnati Children's Hospital, USA
James L. Wynn
University of Florida, USA
Funding for this conference was made possible [in part] by 1R13AI152254-01 from the National Institute of Allergy and Infectious Diseases. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.
The views expressed in this eSymposia are those of the participants and not necessarily of the participants’ organizations or of Keystone Symposia.
This new virtual meeting format came out of difficult circumstances, but your commitment to scientific progress is what inspired us to launch Keystone eSymposia. In these virtual meetings, we are capturing the same innovative essence of our in-person meetings that you've all created as a scientific community. Here, Debbie Johnson, our CEO, explains how we're going to do that.